A Study to Describe the Safety of a Vaccine (Called 13vPnC) in Healthy People 18 to 49 Years of Age in India
NCT05329259
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Pneumococcal Disease
Interventions
BIOLOGICAL:
13-valent pneumococcal conjugate vaccine
Sponsor
Pfizer